OraSure Technologies | OSUR - Sales Revenues


OraSure Technologies reported $26.76M in Sales Revenues for its fiscal quarter ending in December of 2025.





Sales Change Date
Agilent USD 1.84B 37M Mar/2026
AngioDynamics USD 79.43M 3.72M Sep/2025
Becton, Dickinson and Co. USD 4.7B 600M Mar/2026
Bio Techne USD 311.4M 15.5M Mar/2026
Bio-Rad Laboratories USD 592.1M 101.1M Mar/2026
Bruker USD 823.4M 153.8M Mar/2026
Cerus USD 50.81M 4.79M Dec/2024
Charles River Laboratories USD 995.8M 1.6M Mar/2026
Danaher USD 5.95B 890M Mar/2026
Dentsply International USD 880M 81M Mar/2026
Dexcom USD 1.19B 70M Mar/2026
Illumina USD 1.09B 70M Mar/2026
Integra LifeSciences USD 391.9M 43M Mar/2026
Intuitive Surgical USD 2.77B 100M Mar/2026
IQVIA Holdings USD 4.15B 210M Mar/2026
Mesa Laboratories USD 62.84M 5.01M Dec/2024
Mettler Toledo International USD 947.13M 182.87M Mar/2026
Myriad Genetics USD 200.4M 9.4M Mar/2026
OraSure Technologies USD 26.76M 322K Dec/2025
Quidel USD 620M 104M Mar/2026
Repligen USD 194M 3.91M Mar/2026
Revvity USD 711M 61.06M Mar/2026
STAAR Surgical USD 93.5M 145.9M Mar/2026
Thermo Fisher Scientific USD 11.01B 1.2B Mar/2026
Trinity Biotech USD 14.31M 1.55M Sep/2025
Waters USD 1.27B 338M Mar/2026